XML 98 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)
In Millions, unless otherwise specified
Total
Common Stock
Additional Paid-in Capital
Net Unrealized Appreciation on Investments and Derivative Instruments:
Defined Benefit Pension and Postretirement Plans:
Cumulative Foreign Currency Translation Adjustment:
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Retained Earnings
Balance previously reported
Retained Earnings
Balance as adjusted
Treasury Stock
Balance at beginning of period (Cumulative effect of accounting change)               $ (19.5)      
Balance at beginning of period at Dec. 31, 2009   0.6 1,808.5 107.7 (78.9)       1,141.1 1,121.6 (620.4)
Net income 151.2             151.2      
Net actuarial loss arising in the period         (13.9)            
Net appreciation during the period:                      
Net appreciation on available-for-sale securities and derivative instruments 130.7     104.7              
Benefit (provision) for deferred income taxes 5.9     5.9              
Unrealized gains arising during period 139.8     110.6              
Settlement of accelerated share repurchases     (8.7)                
Shares purchased at cost                     (126.0)
Dividends to shareholders               (47.2)      
Amortization during the period:                      
Amount recognized as net periodic benefit cost (4.1)       9.8            
Benefit for deferred income taxes 1.4       1.4            
Total pension and postretirement benefits (2.7)       (2.7)            
Employee and director stock-based awards and other     (3.3)                
Net shares reissued at cost under employee stock-based compensation plans                     26.3
Treasury stock issued for less than cost               (9.7)      
Recognition of employee stock-based compensation               7.8      
Balance at end of period (Cumulative effect of accounting change)               (2.3)      
Balance at end of period at Dec. 31, 2010 2,437.4 0.6 1,796.5 218.3 (81.6)   136.7 1,223.7 1,223.7 1,221.4 (720.1)
Net income 36.7             36.7      
Net actuarial loss arising in the period         (16.0)            
Net appreciation during the period:                      
Net appreciation on available-for-sale securities and derivative instruments 97.8     75.6              
Benefit (provision) for deferred income taxes 14.8     14.8              
Unrealized gains arising during period 121.3     90.4              
Amount recognized as cumulative foreign currency translation during the year (17.7)         (17.7)          
Shares purchased at cost                     (21.7)
Dividends to shareholders               (50.9)      
Amortization during the period:                      
Amount recognized as net periodic benefit cost (5.8)       10.2            
Benefit for deferred income taxes 0.6       0.6            
Total pension and postretirement benefits (5.2)       (5.2)            
Benefit (provision) for deferred income taxes 6.2         6.2          
Employee and director stock-based awards and other     (11.7)                
Net shares reissued at cost under employee stock-based compensation plans                     18.7
Treasury stock issued for less than cost               (6.9)      
Total cumulative foreign currency translation adjustment (11.5)         (11.5)          
Recognition of employee stock-based compensation               11.0      
Balance at end of period at Dec. 31, 2011 2,484.0 0.6 1,784.8 308.7 (86.8) (11.5) 210.4 1,211.3 1,211.3 1,211.3 (723.1)
Net income 55.9             55.9      
Net actuarial loss arising in the period         (24.9)            
Net appreciation during the period:                      
Net appreciation on available-for-sale securities and derivative instruments 186.4     163.5              
Benefit (provision) for deferred income taxes (46.2)     (46.2)              
Unrealized gains arising during period 146.2     117.3              
Amount recognized as cumulative foreign currency translation during the year 12.2         12.2          
Shares purchased at cost                     (20.0)
Dividends to shareholders               (55.1)      
Amortization during the period:                      
Amount recognized as net periodic benefit cost (15.6)       9.3            
Benefit for deferred income taxes 5.8       5.8            
Total pension and postretirement benefits (9.8)       (9.8)            
Benefit (provision) for deferred income taxes (4.3)         (4.3)          
Employee and director stock-based awards and other     2.3                
Net shares reissued at cost under employee stock-based compensation plans                     13.4
Treasury stock issued for less than cost               (6.0)      
Total cumulative foreign currency translation adjustment 7.9         7.9          
Recognition of employee stock-based compensation               5.5      
Balance at end of period at Dec. 31, 2012 $ 2,595.4   $ 1,787.1 $ 426.0 $ (96.6) $ (3.6) $ 325.8 $ 1,211.6     $ (729.7)